Search
Post-Brexit, the UK is still altering and adding its regulations for medical devices. The regulations to be followed in the country are bifurcated geographically – Great Britain (GB) and Northern Ireland (NI). Medicines and Healthcare Products Regulatory Agency (MHRA) is the regulatory authority that looks after medical device. Northern Ireland is required to European Union Medical Devices Regulations (EU MDR) 2017/745 and In Vitro Diagnostic Devices Regulations (IVDR) 2017/746.
Regulatory Authority: Medicines and Healthcare Products Regulatory Agency (MHRA)
Regulation: Medical Devices Regulations (MDR) 2002
Regulatory Pathway: CE marking followed by Notification
Authorized Representative: United Kingdom Responsible Person (UKRP) for Non-UK manufacturers
QMS Requirement: ISO 13485:2016
Assessment of Technical Data: UK Approved Bodies for UKCA marking
Valid Markings: GB – UKCA or CE & NI – CE or CE + UKNI
Submission Format: Paper
The UK Medical device classifications are based on the UK MDR 2002. Classifying the device is the very first step in the entire process of obtaining approval and launching it in the market.
Classification of the device is the very first step in determining the regulatory pathway for the given product. There are about 22 implementing rules for medical devices and are classified as –
Class |
Risk |
Class I |
Low |
Class IIa |
Moderate |
Class IIb |
Moderate to High |
Class III |
High |
Similarly, for IVD, about 7 rules are implemented while classifying into the following four categories –
Class |
Risk |
Class A |
Low |
Class B |
Moderate |
Class C |
Moderate to High |
Class D |
High |
Our company specializes in medical device classification. Freyr has successfully completed device classification for over 50 companies to date in the UK.
Non-UK manufacturers are now required to appoint UKRP mandatorily to place the products in the market.
Freyr has successfully registered and can now act as your UKRP. To get more details on our UKRP services, please visit – www.ukrpservices.com
The manufacturers will now have to appoint a UK-approved body to obtain UKCA marking. Though CE marking is allowed, it is applicable only for a certain time period. The transition timelines for the same are mentioned below –
Freyr is currently supporting many manufacturers with the post-brexit transitions.
Post-market surveillance requirements under UK MDR 2002 are quite stringent to ensure patient/user safety and effectiveness. Currently, the PMS activities include reporting of incidents/findings to the MHRA. The MHRA has released comprehensive guidance on the same.
Freyr has expertise in post-marketing surveillance support in medical writing services.
Our Newsletter